SEATTLE, May 02, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced upcoming data presentations at the 59th ERA Congress from May 19 – 22, 2022, both virtual and live in Paris, France. Two abstracts will be delivered as free communications (15 minute live oral presentations) and three abstracts will be delivered as mini-oral presentations (5 minute pre-recorded presentations).
